Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01710319 · ClinicalTrials.gov registry record
Mechanisms of Immunosurveillance for Lung Cancer
A clinical trial of Lung Cancer, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 119
- Enrollment target
- 1
- Study location
NCT01710319 is a study of Lung Cancer that has completed, run by Washington University School of Medicine. The registered enrollment target is 119 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01710319, a study of Lung Cancer, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate the differences in "natural killer (NK) blood cells, a type of white blood cell that fights infection in the body, among different types of patients that have lung surgery. The four different groups of patients are: * smokers with lung cancer * smokers without lung cancer * non-smokers with lung cancer * non-smokers without lung cancer.
Conditions Studied
Interventions
- OTHER blood draw
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01710319
The ClinicalTrials.gov registry entry for NCT01710319 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which blood draw is the first listed.
NCT01710319 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01710319 about?
NCT01710319 is a clinical study titled "Mechanisms of Immunosurveillance for Lung Cancer". The purpose of this research study is to investigate the differences in "natural killer (NK) blood cells, a type of white blood cell that fights infection in the body, among different types of patients that have lung surgery. The four different groups of patients are: * smokers with lung cancer * s...
What is the current status of trial NCT01710319?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2012-09. Estimated completion is 2016-07-07.
What conditions does trial NCT01710319 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT01710319?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT01710319?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01710319 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.